OpenVSafe by OpenVAERS
Search V-safe

F56-18499-66853

1 vaccination 2 coded responses 2 check-ins 2 free-text entries 0 call cases
Sex
Female
Age at first dose
26-30
ZIP prefix
502 / IA
Registered
2021-10-29
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-10-28
    Dose 1 — Pfizer-BioNTech
  2. 2021-10-29
    Registered in v-safe
  3. 2021-10-29
    Survey response — days 1–6 daily, dose 1
    MedDRA: Ageusia, Respiratory tract congestion — Feeling: Fair · Site: Pain, Redness, Swelling, Itching
    Free text: Congestion, loss of taste
    MedDRA releases: 2024-11 · check-in free text available
  4. 2021-10-30
    Survey response — days 1–6 daily, dose 1
    MedDRA: COVID-19 — Feeling: Fair
    Free text: COVID-19 positive
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12021-10-28Pfizer-BioNTech No

Free text

Release 10 — days 1–6 daily, dose 1

2021-10-29

Systemic reaction (other): Congestion, loss of taste

2021-10-30

Systemic reaction (other): COVID-19 positive

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SROAgeusia · · ✓
SROCOVID-19 · · ✓
SRORespiratory tract congestion · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release